newsfilter
← Latest News
GlobeNewswire·

argenx to Report Third Quarter 2025 Financial Results and Business Update on October 30, 2025

October 23, 2025Amsterdam, the Netherlands – argenx ((Euronext &, NASDAQ:ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that it